Anon (1990). Nordic Council on Medicines: Guidelines for ATC Classification. Oslo: WHO Collaborating Center for Drugs Statistics Methodology.
et al. (2009). The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. Lancet Neurology, 8, 151–157.
Bustin, J. (2009). Atypical antipsychotics and CATIE-AD. Is this a turning point?
Vertex Buenos Aires Argentina, 20, 136–143.
Eggermont, L. H. P., de Vries, K. and Scherder, E. J. A. (2009). Psychotropic medication use and cognition in institutionalized older adults with mild to moderate dementia. International psychogeriatrics/IPA, 21, 286–294.
Finkers, F., Maring, J. G., Boersma, F. and Taxis, K. (2007). A study of medication reviews to identify drug-related problems of polypharmacy patients in the Dutch nursing home setting. Journal of Clinical Pharmacy and Therapeutics, 32, 469–476.
Gustafsson, M., Karlsson, S. and Lövheim, H. (2013). Inappropriate long-term use of antipsychotic drugs is common among people with dementia living in specialized care units. BMC Pharmacology & Toxicology, 14, 10.
Hanlon, J. T.
et al. (1992). A method for assessing drug therapy appropriateness. Journal of Clinical Epidemiology, 45, 1045–1051.
Koopmans, R. T. C. M. (2007). Are psychotropic drugs too frequently prescribed in Dutch nursing homes?
Tijdschrift voor Gerontologie en Geriatrie, 38, 270–273.
Lemmers, O., Kremer, J. A. M. and Borm, G. F. (2007). Incorporating natural variation into IVF clinic league tables. Human Reproduction, 22, 1359–1362.
et al. (2014). Antipsychotic medication use in nursing homes: a proposed measure of quality. International Journal of Geriatric Psychiatry, 29, 1049–1061.
Lustenberger, I., Schüpbach, B., von Gunten, A. and Mosimann, U. (2011). Psychotropic medication use in Swiss nursing homes. Swiss Medical Weekly, 141, 13254.
Oborne, C. A., Hooper, R., Li, K. C., Swift, C. G. and Jackson, S. H. (2002). An indicator of appropriate neuroleptic prescribing in nursing homes. Age and Ageing, 31, 435–439.
Ruths, S., Straand, J. and Nygaard, H. (2001). Psychotropic drug use in nursing homes - diagnostic indications and variations between institutions. European Journal of Clinical Pharmacology, 57, 523–528.
Ruths, S., Straand, J., Nygaard, H. A. and Aarsland, D. (2008). Stopping antipsychotic drug therapy in demented nursing home patients: a randomized, placebo-controlled study-the bergen district nursing home study (BEDNURS). International Journal of Geriatric Psychiatry, 23, 889–895.
Schneider, L. S., Dagerman, K. and Insel, P. S. (2006). Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. The American Journal of Geriatric Psychiatry, 14, 191–210.
Seitz, D. P.
et al. (2013). Pharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: a systematic review. International Psychogeriatrics/IPA, 25, 185–203.
Selbaek, G., Kirkevold, Ø. and Engedal, K. (2007). The prevalence of psychiatric symptoms and behavioural disturbances and the use of psychotropic drugs in Norwegian nursing homes. International Journal of Geriatric Psychiatry, 22, 843–849.
et al. (2008). Probleemgerdag. [Guideline]
Smeets, C. H.
et al. (2014). Factors related to psychotropic drug prescription for neuropsychiatric symptoms in nursing home residents with dementia. Journal of the American Medical Directors Association, 15, 835–840.
Uzun, S., Kozumplik, O., Jakovljević, M. and Sedić, B. (2010). Side effects of treatment with benzodiazepines. Psychiatr Danub, 22, 90–93.
van der Spek, K.
et al. (2013). PROPER I: frequency and appropriateness of psychotropic drugs use in nursing home patients and its associations: a study protocol. BMC Psychiatry, 13, 307.
van der Spek, K.
et al. (2015). A reliable and valid index was developed to measure appropriate psychotropic drug use in dementia. Journal of Clinical Epidemiology, 68, 903–912.
van Iersel, M. B., Zuidema, S. U., Koopmans, R. T., Verhey, F. R. and Olde Rikkert, M. (2005). Antipsychotics for behavioural and psychological problems in elderly people with dementia: a systematic review of adverse events. Drugs Aging, 22, 845–858.
et al. (2014). Quality of psychopharmacological medication prescribing and mortality in medicare beneficiaries in nursing homes. Journal of the American Geriatrics Society, 62, 1490–1504.
Wetzels, R. B., Zuidema, S. U., de Jonghe, J. F., Verhey, F. R. and Koopmans, R. T. (2011). Prescribing pattern of psychotropic drugs in nursing home residents with dementia. International Psychogeriatrics IPA, 23, 1249–1259.
Zuidema, S. U., de Jonghe, J. F., Verhey, F. R. and Koopmans, R. T. (2007a). Neuropsychiatric symptoms in nursing home patients: factor structure invariance of the Dutch nursing home version of the neuropsychiatric inventory in different stages of dementia. Dementia and Geriatric Cognitive Disorders, 24, 169–176.
Zuidema, S. U., Derksen, E., Verhey, F. R. and Koopmans, R. T. (2007b). Prevalence of neuropsychiatric symptoms in a large sample of Dutch nursing home patients with dementia. International Journal of Geriatric Psychiatry, 22, 632–638.
Zuidema, S. U., de Jonghe, J. F., Verhey, F. R. and Koopmans, R. T. (2011). Psychotropic drug prescription in nursing home patients with dementia: influence of environmental correlates and staff distress on physicians’ prescription behavior. International Psychogeriatrics/IPA, 23, 1632–1639.
Zwijsen, S. A.
et al. (2014). Coming to grips with challenging behavior: a cluster randomized controlled trial on the effects of a multidisciplinary care program for challenging behavior in dementia. Journal of the American Medical Directors Association, 15, 531.e1–531.e10.